tiprankstipranks
CareMax (CMAXQ)
OTHER OTC:CMAXQ
US Market
Holding CMAXQ?
Track your performance easily

CareMax (CMAXQ) Income Statement

131 Followers

CareMax Income Statement

Last quarter (Q2 2024), CareMax's total revenue was $198.63M, a decrease of -11.50% from the same quarter last year. In Q2, CareMax's net income was $-170.56M. See CareMax’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 784.55M$ 751.10M$ 631.13M$ 295.76M
Cost of Revenue
$ 390.71M$ 737.20M$ 550.83M$ 264.31M
Gross Profit
$ 244.54M$ 13.90M$ 80.30M$ 31.45M
Operating Expense
$ 218.27M$ 122.75M$ 109.30M$ 324.58M
Operating Income
$ -718.23M$ -656.15M$ -112.17M$ -28.82M
Net Non Operating Interest Income Expense
$ -70.91M$ -54.43M$ 20.45M$ -4.49M
Other Income Expense
$ -367.01M$ -520.93M$ -7.88M$ -26.80M
Pretax Income
$ -783.72M$ -684.21M$ -57.34M$ -6.52M
Tax Provision
$ -863.00K$ -863.00K$ -19.54M$ 159.00K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -782.86M$ -683.35M$ -37.80M$ 487.98M
Basic EPS
$ -208.79$ -183.31$ -12.60$ -3.90
Diluted EPS
$ -208.79$ -183.31$ -12.60$ -3.90
Basic Average Shares
$ 15.06M$ 3.73M$ 3.03M$ 1.75M
Diluted Average Shares
$ 15.06M$ 3.73M$ 3.03M$ 1.75M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 1.50B$ 859.95M$ 660.13M$ 324.58M
Net Income From Continuing And Discontinued Operation
$ -782.86M$ -683.35M$ -37.80M$ -6.67M
Normalized Income
$ -180.29M$ -157.68M--
Interest Expense
----
EBIT
$ -549.77M$ -629.78M$ -36.88M$ -2.02M
EBITDA
$ -509.33M$ -590.46M$ -15.16M$ 11.19M
Currency in USD

CareMax Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis